HomeCompareJNJ vs APD

JNJ vs APD: Dividend Comparison 2026

JNJ yields 2.14% · APD yields 2.46%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 APD wins by $53.9K in total portfolio value
10 years
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →
APD
APD
● Live price
2.46%
Share price
$291.56
Annual div
$7.16
5Y div CAGR
42.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$84.4K
Annual income
$25,407.75
Full APD calculator →

Portfolio growth — JNJ vs APD

📍 APD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJNJAPD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JNJ + APD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JNJ pays
APD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
APD
Annual income on $10K today (after 15% tax)
$208.74/yr
After 10yr DRIP, annual income (after tax)
$21,596.59/yr
At 15% tax rate, APD beats the other by $17,559.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JNJ + APD for your $10,000?

JNJ: 50%APD: 50%
100% APD50/50100% JNJ
Portfolio after 10yr
$57.4K
Annual income
$15,078.81/yr
Blended yield
26.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on APD right now

JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
APD
Analyst Ratings
23
Buy
19
Hold
Consensus: Buy
Price Target
$296.33
+1.6% upside vs current
Range: $255.00 — $335.00
Altman Z
2.6
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JNJ buys
0
APD buys
0
No recent congressional trades found for JNJ or APD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJNJAPD
Forward yield2.14%2.46%
Annual dividend / share$5.20$7.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR28%42.5%
Portfolio after 10y$30.5K$84.4K
Annual income after 10y$4,749.88$25,407.75
Total dividends collected$15.6K$58.3K
Payment frequencyquarterlyquarterly
SectorHealthcareMaterials
Analyst consensusBuyBuy
Analyst price target$228.73$296.33

Year-by-year: JNJ vs APD ($10,000, DRIP)

YearJNJ PortfolioJNJ Income/yrAPD PortfolioAPD Income/yrGap
1← crossover$10,594$274.49$11,050$349.95$456.00APD
2$11,294$360.69$12,338$514.98$1.0KAPD
3$12,133$476.91$13,968$765.81$1.8KAPD
4$13,156$635.42$16,100$1,154.58$2.9KAPD
5$14,432$854.61$19,000$1,772.38$4.6KAPD
6$16,056$1,162.76$23,115$2,785.49$7.1KAPD
7$18,175$1,604.53$29,246$4,513.18$11.1KAPD
8$21,009$2,252.68$38,898$7,604.83$17.9KAPD
9$24,911$3,229.73$55,092$13,470.41$30.2KAPD
10$30,458$4,749.88$84,356$25,407.75$53.9KAPD

JNJ vs APD: Complete Analysis 2026

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

APDMaterials

Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and services worldwide. The company produces atmospheric gases, including oxygen, nitrogen, and argon; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, syngas; specialty gases; and equipment for the production or processing of gases comprising air separation units and non-cryogenic generators for customers in various industries, including refining, chemical, gasification, metals, manufacturing, food and beverage, electronics, magnetic resonance imaging, energy production and refining, and metals. It also designs and manufactures equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction, and liquid helium and liquid hydrogen transport and storage. Air Products and Chemicals, Inc. has a strategic collaboration with Baker Hughes Company to develop hydrogen compression systems. The company was founded in 1940 and is headquartered in Allentown, Pennsylvania.

Full APD Calculator →
📬

Get this JNJ vs APD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JNJ vs ABBVJNJ vs MRKJNJ vs PFEJNJ vs BMYJNJ vs LLYJNJ vs SCHDJNJ vs JEPIJNJ vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.